Paperonium

Vaccines · Lancet Infect Dis · 2021

The Pfizer vaccine’s 71.4% for over-80s is right; the summary gives it an AstraZeneca result’s range.

The paper’s own table: Pfizer71.4%The paper’s summary: Pfizer71.4%Table: AstraZeneca,simpler estimate76.7%; same range43.1 to 86.2%46.5 to 90.6%0%20%40%60%80%100%no protection at all
The paper’s owntable: Pfizer71.4%The paper’ssummary: Pfizer71.4%Table:AstraZeneca,simpler estimate76.7%;same range86.2%43.1%90.6%46.5%0%50%100%no protection at all

Over-80s: how much one dose cut COVID-19 hospital admissions. Dot: result; bar: plausible range.

The paper says

The paper’s summary, the short overview at the top: in people aged 80 or over, one dose of the Pfizer vaccine cut the chance of being admitted to hospital with COVID-19 by 71.4%, with a range of 46.5% to 90.6%.

Its own data show

The 71.4% is right. But the paper’s detailed results, in its text and table, give it a range of 43.1% to 86.2%. The summary’s 46.5 to 90.6 matches, digit for digit, only one row of that table: AstraZeneca’s vaccine, in a simpler estimate (76.7%) made before allowing for differences between the people compared.

A range is the span of results the data plausibly fit; its low end is the least protection one dose plausibly gives. The summary, the most-read part, sets both ends too high (by 3.4 and 4.4 points), so the worst case looks better. An article printed alongside repeats the wrong range; no correction yet. The 71.4% and conclusion stand.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study · Lancet Infect Dis (2021) · doi:10.1016/S1473-3099(21)00330-3